Cabotegravir (Apretude)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cabotegravir (Apretude), covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV